bpc 157 for pain relief Wellness clinics promote the use of BPC-157 recovery from injury or surgery. What do we know about it? It is effective in rodent models. Why might you think twice before using Would a peptide like BPC

Using untested peptides from unknown sources is gambling with your health and your wallet

Compliance Red Flags (Common in the Peptide Market) Calling compounded peptides FDA-approved (or implying they are) Claiming a compounded peptide treats a disease without context Before/after marketing that implies predictable outcomes Influencer-style performance claims (healed my tendon in 10 days) presented as representative Broad telehealth funnels that look like mass manufacturing instead of patient-specific compounding Timeline Check: What Happens Next (and Key Dates) The FDA meeting page states that the docket for public comment is FDA-2025-N-6895 and closes July 22, 2026 (FDA advisory committee calendar)

Fendrick AM, Monto AS, Nightengale B, Sarnes M

Note: The above statements have not been evaluated by the Food and Drug Administration